Company: RCUS
Filing Date: 2025-02-19
Form Type: 8-K
Source: 0001193125-25-029591
Chunk: 0

Company: Arcus Biosciences, Inc.
Filing Date: 2025-02-19
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01      Other Events.  

On February 18, 2025, Arcus Biosciences, Inc. (the “ Company”) entered into an underwriting agreement (the “ Underwriting Agreement”) with Goldman Sachs & Co. LLC and Leerink Partners LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters”), in connection with the offering, issuance and sale by the Company of 13,636,364 shares of the Company’s common stock, $0.0001 par value per share (the “ Common Stock”), at an offering price of $11.00 per share, less underwriting discounts and commissions, pursuant to an effective shelf registration statement on FormS-3(Registration No. 333-270132). A prospectus supplement relating to the offer and sale of the shares was filed with the Securities and Exchange Commission on February 18, 2025. The closing of the offering occurred on February 19, 2025.